BBA
IONS icon

Baader Bank Aktiengesellschaft’s Ionis Pharmaceuticals IONS Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,097
Closed -$866K – 490
2025
Q4 		$866K Buy
11,097
+869
+8% +$65.4K 0.06% 202
2025
Q3 		$668K Buy
+10,228
New +$499K 0.04% 234

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baader Bank Aktiengesellschaft's IONS Position: Q1 2026 in Review

Baader Bank Aktiengesellschaft sold out of Ionis Pharmaceuticals (IONS) in Q1 2026, closing a stake of 11,097 shares — an estimated $866K sold.

Baader Bank Aktiengesellschaft first reported a position in IONS in Q3 2025 and held it in 2 quarters. The position peaked at $866K in Q4 2025. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Baader Bank Aktiengesellschaft reported no remaining Ionis Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 11,097 Ionis Pharmaceuticals shares in Q1 2026, an estimated $866K.
  • Baader Bank Aktiengesellschaft first reported a position in Ionis Pharmaceuticals in Q3 2025 and held it in 2 quarters.
  • Baader Bank Aktiengesellschaft's Ionis Pharmaceuticals position peaked at $866K in Q4 2025.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2026, filed 8 May 2026.